These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 26425463)

  • 21. Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases.
    Ghittoni R; Patrussi L; Pirozzi K; Pellegrini M; Lazzerini PE; Capecchi PL; Pasini FL; Baldari CT
    FASEB J; 2005 Apr; 19(6):605-7. PubMed ID: 15677697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications for statin pleiotropy.
    Liao JK
    Curr Opin Lipidol; 2005 Dec; 16(6):624-9. PubMed ID: 16276239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins: maid-of-all-work in cardiovascular diseases!
    Nalbone G; Bernot D; Peiretti F; Alessi MC
    Arch Mal Coeur Vaiss; 2003 Mar; 96(3):207-13. PubMed ID: 12722551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.
    Tanaka T; Tatsuno I; Uchida D; Moroo I; Morio H; Nakamura S; Noguchi Y; Yasuda T; Kitagawa M; Saito Y; Hirai A
    J Neurosci; 2000 Apr; 20(8):2852-9. PubMed ID: 10751437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation.
    Weivoda MM; Hohl RJ
    Endocrinology; 2011 Aug; 152(8):3113-22. PubMed ID: 21586555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pleiotropic effects of statins.
    Liao JK; Laufs U
    Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statins and their role in vascular protection.
    Mason JC
    Clin Sci (Lond); 2003 Sep; 105(3):251-66. PubMed ID: 12793855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.
    Danesh FR; Sadeghi MM; Amro N; Philips C; Zeng L; Lin S; Sahai A; Kanwar YS
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8301-5. PubMed ID: 12048257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential antitumor effects of statins (Review).
    Jakobisiak M; Golab J
    Int J Oncol; 2003 Oct; 23(4):1055-69. PubMed ID: 12963986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins: Complex outcomes but increasingly helpful treatment options for patients.
    Mohammadkhani N; Gharbi S; Rajani HF; Farzaneh A; Mahjoob G; Hoseinsalari A; Korsching E
    Eur J Pharmacol; 2019 Nov; 863():172704. PubMed ID: 31568783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I.
    Martin G; Duez H; Blanquart C; Berezowski V; Poulain P; Fruchart JC; Najib-Fruchart J; Glineur C; Staels B
    J Clin Invest; 2001 Jun; 107(11):1423-32. PubMed ID: 11390424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rho GTPases, statins, and nitric oxide.
    Rikitake Y; Liao JK
    Circ Res; 2005 Dec; 97(12):1232-5. PubMed ID: 16339495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statins and thrombin.
    Fenton JW; Brezniak DV; Ofosu FA; Shen GX; Jacobson JR; Garcia JG
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Apr; 5(2):115-20. PubMed ID: 15853752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-inflammatory and immunomodulatory effects of statins.
    Blanco-Colio LM; Tuñón J; Martín-Ventura JL; Egido J
    Kidney Int; 2003 Jan; 63(1):12-23. PubMed ID: 12472764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct vascular effects of HMG-CoA reductase inhibitors.
    Laufs U; Liao JK
    Trends Cardiovasc Med; 2000 May; 10(4):143-8. PubMed ID: 11239793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Novel actions of HMG-CoA reductase inhibitors(statins)--vascular and cerebral protection through inhibition of small GTPase Rho].
    Sawada N; Itoh H; Nakao K
    Nihon Rinsho; 2001 Dec; 59(12):2470-5. PubMed ID: 11766357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production.
    Amuro H; Ito T; Miyamoto R; Sugimoto H; Torii Y; Son Y; Nakamichi N; Yamazaki C; Hoshino K; Kaisho T; Ozaki Y; Inaba M; Amakawa R; Fukuhara S
    Arthritis Rheum; 2010 Jul; 62(7):2073-85. PubMed ID: 20506142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pleiotropic Effects of Statins on the Cardiovascular System.
    Oesterle A; Laufs U; Liao JK
    Circ Res; 2017 Jan; 120(1):229-243. PubMed ID: 28057795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.
    Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M
    Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.